Colorectal Cancer Therapeutics strategies and Product Pipeline Review 2017

Pune, India, 13th October 2017: WiseGuyReports announced addition of new report, titled “Colorectal Cancer Drug Development Pipeline Review, 2017”.

Pune, India - October 13, 2017 /MarketersMedia/ —

Summary
This report provides an overview of the colorectal cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for anal, rectal and colorectal cancer, and features dormant and discontinued projects.

Anal cancer starts in the anus. Symptoms include rectal bleeding, rectal itching, a lump or mass at the anal opening, pain or a feeling of fullness in the anal area, narrowing of stool, pain or a feeling of fullness in the anal area

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2385276-colorectal-cancer-drug-development-pipeline-review-2017

Rectal cancer affects the lower part of the colon, which connects the large bowel to the anus. The common signs and symptoms of rectal cancer include a change in bowel habits, diarrhea, constipation, or feeling that the bowel does not empty completely, blood, either bright red or very dark in the stool, stools that are narrower than usual, general abdominal discomfort such as frequent gas pains, bloating, fullness or cramps, weight loss with no known reason, constant tiredness and vomiting.

Finally, colorectal cancer is a cancer that starts in the colon or the rectum. Colorectal cancers begin as a growth called a polyp on the inner lining of the colon or rectum. Symptoms include abdominal pain and tenderness in the lower abdomen, blood in the stool, diarrhea, constipation, change in bowel habits, narrow stools and weight loss with no known reason.

The size of these pipelines ranges from 10 products in rectal cancer to 581 products in colorectal cancer. Across all three of these indications, however, kinases, immune-related proteins, DNA-related proteins and viral proteins are common targets, closely reflecting the current treatment landscape of these diseases.

Scope
- Which companies are the most active within the pipeline for colorectal cancer therapeutics?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in the field of colorectal cancer?

Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

Table of Content: Key Points
1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 10
2 Introduction 11
2.1 Colorectal Cancer Report Coverage 11
2.2 Anal Cancer - Overview 11
2.3 Rectal Cancer - Overview 11
2.4 Colorectal Cancer - Overview 11
3 Therapeutics Development 12
3.1 Anal Cancer 12
3.2 Rectal Cancer 16
3.3 Colorectal Cancer 18
4 Therapeutics Assessment 56
4.1 Anal Cancer 56
4.2 Rectal Cancer 63
4.3 Colorectal Cancer 71
5 Companies Involved in Therapeutics Development 100
5.1 Anal Cancer 100
5.2 Rectal Cancer 108
5.3 Colorectal Cancer 114
6 Dormant Projects 241
6.1 Anal Cancer 241
6.2 Rectal Cancer 241
6.3 Colorectal Cancer 242
7 Discontinued Products 261
7.1 Anal Cancer 261
7.2 Colorectal Cancer 261
8 Product Development Milestones 265
8.1 Anal Cancer 265
8.2 Rectal Cancer 278
8.3 Colorectal Cancer 280
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/2385276-colorectal-cancer-drug-development-pipeline-review-2017

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers
Phone: +91 841 198 5042

Source URL: https://marketersmedia.com/colorectal-cancer-therapeutics-strategies-and-product-pipeline-review-2017/250073

For more information, please visit http://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 250073

More News From Daily World Feed

Global markets rebound after Wall St falls on Turkey jitters

Aug 14, 2018

BEIJING — Most global stock markets rebounded Tuesday after Wall Street slid on worries Turkey's currency crisis will hurt other emerging markets. KEEPING SCORE: In early trading, Germany's DAX rose 0.7 percent to 12,441.97 and France's CAC 40 gained 0.4 percent to 5,432.48. London's FTSE 100 added 0.2 percent to 7,662.81. On Monday, the DAX fell 0.5 percent, the FTSE 100 shed 0.3 percent and the CAC 40 lost under 0.1 percent. On Wall Street, futures for the Standard & Poor's 500 index and Dow Jones industrial average were up 0.4 percent. ASIA'S DAY: The Shanghai Composite Index lost 0.2...

Taliban overrun Afghan army base, kill 17 troops

Aug 14, 2018

KABUL, Afghanistan — The Taliban overran a base in northern Afghanistan, killing 17 soldiers, even as Afghan forces battled the insurgents for the fifth straight day in the eastern provincial capital of Ghazni on Tuesday, trying to flush them out of the city's outskirts, officials said. There were fears for the fate of the other troops from the base, known as Camp Chinaya, as the Taliban claimed that dozens had surrendered to them while others were captured in battle. The attack in the north took place in Faryab province, in the district of Ghormach, according to the spokesman for the...

With gun salutes, Pakistan marks 71 years of independence

Aug 14, 2018

ISLAMABAD — Pakistan has kicked off a day of celebrations marking the country's 71 years of statehood and independence. This year, the anniversary comes amid political change with a new government taking over following the July 25 general elections. Pakistan's former cricket-star-turned-politician Imran Khan is to become the next prime minister. President Mamnoon Hussain hoisted the national flag at a ceremony in Islamabad on Tuesday while Pakistanis across the country raised the banner at their homes and on their cars. Fireworks erupted over the capital, Islamabad, at midnight on Monday, ushering in the festivities. During the day, gun salutes were...

The Latest: Taliban storm Afghan army base, kill 17 troops

Aug 14, 2018

KABUL, Afghanistan — The Latest on developments in Afghanistan after a surge in Taliban attacks (all times local): 11:30 a.m. The spokesman for the Defense Ministry in Kabul says the Taliban have overrun a military base in northern Afghanistan, killing 17 soldiers and wounding at least 19 troops. Ghafor Ahmad Jawed says the insurgents overrun the base late on Monday night in Faryab province, in the district of Ghormach, after besieging it for three days. The local provincial council chief, Mohammad Tahir Rahmani, says 43 troops were killed and wounded in the attack but didn't give a breakdown. He says...

Beijing appeals to US for fairness under investment law

Aug 14, 2018

BEIJING — China appealed to Washington on Tuesday not to misuse security concerns to hamper business activity after President Donald Trump signed a law that expands the jurisdiction of an investment review panel. The law signed Monday by Trump expands the authority of a government security panel to scrutinize foreign investments. It was prompted by complaints Chinese companies were taking advantage of gaps in U.S. law and improperly obtaining technology and possibly sensitive information. "The United States should treat Chinese investors objectively and fairly and avoid making a national security review an obstacle to Chinese-U.S. enterprises' investment cooperation," said a...

About Us

Get yourself immersed in engaging topics right here. Daily World Feed is a multi-platform media, providing you latest breaking news straight from the industry.

Contact us: sales[at]dailyworldfeed.com

Subscribe Now!